These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program. Lapane KL, Jakiche AF, Sugano D, Weng CS, Carey WD. Am J Gastroenterol; 1998 Apr; 93(4):591-6. PubMed ID: 9576453 [Abstract] [Full Text] [Related]
4. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico. Calderón GM, González-Velázquez F, González-Bonilla CR, Novelo-Garza B, Terrazas JJ, Martínez-Rodríguez ML, Cortés-Márquez SR, Blanco-Flores JP, Rodríguez-Rodríguez A, Del Campo MA, Cortés-Gómez R, Mejía-Bocanegra MG. Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543 [Abstract] [Full Text] [Related]
5. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, Dias MA, Gomes SA, Yoshida CF, Martins RM. Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340 [Abstract] [Full Text] [Related]
6. Surveillance for acute viral hepatitis - United States, 2007. Daniels D, Grytdal S, Wasley A, Centers for Disease Control and Prevention (CDC). MMWR Surveill Summ; 2009 May 22; 58(3):1-27. PubMed ID: 19478727 [Abstract] [Full Text] [Related]
7. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. Guadagnino V, Zimatore G, Izzi A, Caroleo B, Rocca A, Montesano F, Costa C, Masciari R, Naso E, Biselli R. J Clin Lab Immunol; 1995 May 22; 47(1):1-9. PubMed ID: 8735431 [Abstract] [Full Text] [Related]
11. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bovet P, Yersin C, Herminie P, Lavanchy D, Frei PC. Bull World Health Organ; 1999 May 22; 77(11):923-8. PubMed ID: 10612888 [Abstract] [Full Text] [Related]
12. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission. Di Stefano R, Stroffolini T, Ferraro D, Usticano A, Valenza LM, Montalbano L, Pomara G, Craxì A. J Med Virol; 2002 Jul 22; 67(3):339-44. PubMed ID: 12116024 [Abstract] [Full Text] [Related]
13. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S. Isr Med Assoc J; 2008 Nov 22; 10(11):775-8. PubMed ID: 19070285 [Abstract] [Full Text] [Related]
18. [Seroprevalence of the infection and risk factors of hepatitis B and C in healthy military personnel]. Chacaltana A, Espinoza J. Rev Gastroenterol Peru; 2008 Nov 22; 28(3):217-25. PubMed ID: 18958136 [Abstract] [Full Text] [Related]
19. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. J Med Virol; 2005 Dec 22; 77(4):491-9. PubMed ID: 16254981 [Abstract] [Full Text] [Related]
20. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India. Tripathi AK, Khanna M, Gupta N, Chandra M. J Assoc Physicians India; 2007 Jun 22; 55():429-31. PubMed ID: 17879496 [Abstract] [Full Text] [Related] Page: [Next] [New Search]